| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia.
|
J Rheumatol
|
2012
|
2.18
|
|
2
|
Serum amyloid-A in Behçet's disease.
|
Clin Rheumatol
|
2014
|
1.47
|
|
3
|
The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study.
|
Clin Rheumatol
|
2011
|
1.15
|
|
4
|
The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study.
|
J Rheumatol
|
2011
|
1.01
|
|
5
|
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome.
|
Int J Rheum Dis
|
2013
|
0.98
|
|
6
|
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs.
|
Clin Rheumatol
|
2010
|
0.97
|
|
7
|
Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients.
|
Clin Rheumatol
|
2014
|
0.94
|
|
8
|
The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate.
|
Clin Rheumatol
|
2007
|
0.94
|
|
9
|
Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series.
|
Dermatology
|
2014
|
0.94
|
|
10
|
The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy.
|
Clin Rheumatol
|
2014
|
0.93
|
|
11
|
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.
|
Clin Rheumatol
|
2014
|
0.91
|
|
12
|
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues.
|
Int J Rheumatol
|
2013
|
0.91
|
|
13
|
New developments in magnetic resonance imaging of the nail unit.
|
J Rheumatol Suppl
|
2012
|
0.91
|
|
14
|
The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection.
|
Clin Rheumatol
|
2014
|
0.87
|
|
15
|
Blockade of intra-articular TNF in peripheral spondyloarthritis: its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers.
|
Joint Bone Spine
|
2012
|
0.87
|
|
16
|
Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-α blockers for psoriatic arthritis.
|
J Rheumatol Suppl
|
2012
|
0.86
|
|
17
|
Current management of differentiated thyroid carcinoma.
|
Med Sci Monit
|
2005
|
0.85
|
|
18
|
Osteoporosis and psoriatic arthritis.
|
J Rheumatol Suppl
|
2012
|
0.84
|
|
19
|
JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis.
|
Immunol Res
|
2014
|
0.83
|
|
20
|
Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis.
|
Clin Rheumatol
|
2014
|
0.80
|
|
21
|
The occurrence of lower limb enthesopathy in coeliac disease patients without clinical signs of articular involvement.
|
Rheumatology (Oxford)
|
2013
|
0.79
|
|
22
|
Magnetic resonance imaging of nail unit in psoriatic arthritis.
|
J Rheumatol Suppl
|
2009
|
0.78
|
|
23
|
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.
|
Expert Opin Biol Ther
|
2015
|
0.78
|
|
24
|
Psoriatic arthritis: advances in pharmacotherapy based on molecular target.
|
Expert Opin Pharmacother
|
2013
|
0.78
|
|
25
|
Working the endless puzzle of hereditary autoinflammatory disorders.
|
Mod Rheumatol
|
2013
|
0.77
|
|
26
|
The enthesopathy of celiac patients: effects of gluten-free diet.
|
Clin Rheumatol
|
2014
|
0.77
|
|
27
|
New chiral selectors: design and synthesis of 6-TBDMS-2,3-methyl beta-cyclodextrin 2-2' thioureido dimer and 6-TBDMS-2,3-methyl (or 2-methyl-3-acetyl) beta-cyclodextrin bearing an (R) Mosher acid moiety.
|
Chirality
|
2004
|
0.77
|
|
28
|
Refractory pemphigus foliaceus and Behçet's disease successfully treated with tocilizumab.
|
Immunol Res
|
2013
|
0.76
|
|
29
|
Blau syndrome and latent tubercular infection: an unresolved partnership.
|
Int J Rheum Dis
|
2014
|
0.76
|
|
30
|
Early psoriatic arthritis.
|
J Rheumatol Suppl
|
2009
|
0.76
|
|
31
|
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis.
|
Clin Rheumatol
|
2015
|
0.76
|
|
32
|
Psoriatic arthritis and TNF inhibitors: advances on effectiveness and toxicity.
|
Expert Opin Biol Ther
|
2014
|
0.75
|
|
33
|
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer.
|
J Clin Rheumatol
|
2011
|
0.75
|
|
34
|
Effectiveness of Adalimumab in Non-radiographic Axial Spondyloarthritis: Evaluation of Clinical and Magnetic Resonance Imaging Outcomes in a Monocentric Cohort.
|
Medicine (Baltimore)
|
2015
|
0.75
|
|
35
|
Thalassemic trait prevalence in patients affected by psoriatic arthritis in anti-TNF treatment.
|
Drug Dev Res
|
2014
|
0.75
|